✦ LIBER ✦

Design and Rationale of Low-Dose Erythropoietin in Patients with ST-Segment Elevation Myocardial Infarction (EPO-AMI-II Study): A Randomized Controlled Clinical Trial

✍ Scribed by Tetsuo Minamino, Ken Toba, Shuichiro Higo, Daisaku Nakatani, Shungo Hikoso, Masao Umegaki, Kouji Yamamoto, Yoshiki Sawa, Yoshifusa Aizawa, Issei Komuro

Book ID: 118797346
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 270 KB
Volume: 26
Category: Article
ISSN: 0920-3206
DOI: 10.1007/s10557-012-6410-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thrombus Aspiration in ST-Elevation myoc

Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale

✍ Ole Fröbert; Bo Lagerqvist; Thórarinn Gudnason; Leif Thuesen; Roger Svensson; Gö 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 170 KB

Rationale and design of the INFUSE-AMI s

Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior ST-segment elevation myocardial infarction

✍ C. Michael Gibson; Akiko Maehara; Alexandra J. Lansky; Jochen Wohrle; Tom Stucke 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 826 KB

The Early Glycoprotein IIb/IIIa Inhibiti

The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale

✍ Robert P. Giugliano; L. Kristin Newby; Robert A. Harrington; C. Michael Gibson; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 148 KB

Intracoronary Compared to Intravenous Ab

Intracoronary Compared to Intravenous Abciximab and High-Dose Bolus Compared to Standard Dose in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Transradial Primary Percutaneous Coronary Intervention: a Two-by-Two Factorial Placebo-Controlled Randomized Study

✍ Olivier F. Bertrand; Josep Rodés-Cabau; Éric Larose; Stéphane Rinfret; Valérie G 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 594 KB

A unicenter, randomized, double-blind, p

A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty: The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: Study design and rationale

✍ Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Martín J. Garcia-Gonzalez; Ju 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 137 KB

A Comparison of prasugrel at the time of

A Comparison of prasugrel at the time of percutaneous Coronary intervention or as pretreatment at the time of diagnosis in patients with non–ST-segment elevation myocardial infarction: Design and rationale for the ACCOAST study

✍ Gilles Montalescot; Leonardo Bolognese; Dariusz Dudek; Patrick Goldstein; Christ 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 158 KB